Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Stroke

Retrieve available abstracts of 97 articles:
HTML format

Single Articles

    July 2022
  1. IVANY E, Ritchie LA, Lip GYH, Lotto RR, et al
    Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis.
    Stroke. 2022 Jul 8:101161STROKEAHA122038752. doi: 10.1161/STROKEAHA.122.038752.
    PubMed     Abstract available

  2. PUY L, Forman R, Cordonnier C, Sheth KN, et al
    Protecting the Brain, From the Heart: Safely Mitigating the Consequences of Thrombosis in Intracerebral Hemorrhage Survivors With Atrial Fibrillation.
    Stroke. 2022;53:2152-2160.
    PubMed     Abstract available

    June 2022
  3. MANWANI B, Finger C, Lisabeth L
    Strategies for Maintaining Brain Health: The Role of Stroke Risk Factors Unique to Elderly Women.
    Stroke. 2022 Jun 2:STROKEAHA121036894. doi: 10.1161/STROKEAHA.121.036894.
    PubMed     Abstract available

    May 2022
  4. PACIARONI M, Caso V, Agnelli G, Mosconi MG, et al
    Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study.
    Stroke. 2022 May 11:101161STROKEAHA121038239. doi: 10.1161/STROKEAHA.121.038239.
    PubMed     Abstract available

  5. EDWARD JA, Cornwell WK 3rd
    Impact of Exercise on Cerebrovascular Physiology and Risk of Stroke.
    Stroke. 2022 May 4:101161STROKEAHA121037343. doi: 10.1161/STROKEAHA.121.037343.
    PubMed     Abstract available

    April 2022
  6. YOSHIMOTO T, Toyoda K, Ihara M, Inoue H, et al
    Impact of Previous Stroke on Clinical Outcome in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Registry.
    Stroke. 2022 Apr 20:101161STROKEAHA121038285. doi: 10.1161/STROKEAHA.121.038285.
    PubMed     Abstract available

  7. NIELSEN PB, Melgaard L, Overvad TF, Jensen M, et al
    Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study.
    Stroke. 2022 Apr 13:101161STROKEAHA121038331. doi: 10.1161/STROKEAHA.121.038331.
    PubMed     Abstract available

    March 2022
  8. BUCKLEY BJR, Harrison SL, Hill A, Underhill P, et al
    Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke.
    Stroke. 2022 Mar 31:STROKEAHA121037316. doi: 10.1161/STROKEAHA.121.037316.
    PubMed     Abstract available

  9. OAK S, Cucchiara BL, Thau L, Nguyen TN, et al
    Age Alters Prevalence of Left Atrial Enlargement and Nonstenotic Carotid Plaque in Embolic Stroke of Undetermined Source.
    Stroke. 2022 Mar 31:101161STROKEAHA121037522. doi: 10.1161/STROKEAHA.121.037522.
    PubMed     Abstract available

    February 2022
  10. KIM D, Yang PS, Sung JH, Jang E, et al
    Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation.
    Stroke. 2022 Feb 3:STROKEAHA121036757. doi: 10.1161/STROKEAHA.121.036757.
    PubMed     Abstract available

  11. KIMURA S, Toyoda K, Yoshimura S, Minematsu K, et al
    Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study.
    Stroke. 2022 Feb 2:STROKEAHA121036695. doi: 10.1161/STROKEAHA.121.036695.
    PubMed     Abstract available

    January 2022
  12. BAKER AD, Schwamm LH, Sanborn DY, Furie K, et al
    Acute Ischemic Stroke, Depressed Left Ventricular Ejection Fraction, and Sinus Rhythm: Prevalence and Practice Patterns.
    Stroke. 2022 Jan 28:STROKEAHA121036706. doi: 10.1161/STROKEAHA.121.036706.
    PubMed     Abstract available

  13. SPOSATO LA, Chaturvedi S, Hsieh CY, Morillo CA, et al
    Atrial Fibrillation Detected After Stroke and Transient Ischemic Attack: A Novel Clinical Concept Challenging Current Views.
    Stroke. 2022 Jan 5:STROKEAHA121034777. doi: 10.1161/STROKEAHA.121.034777.
    PubMed     Abstract available

  14. SANDSET EC, Goldstein LB
    Advances in Stroke: Treatments-Preventive.
    Stroke. 2022 Jan 5:STROKEAHA121036977. doi: 10.1161/STROKEAHA.121.036977.

    December 2021
  15. FRERICH S, Malik R, Georgakis MK, Sinner MF, et al
    Cardiac Risk Factors for Stroke: A Comprehensive Mendelian Randomization Study.
    Stroke. 2021 Dec 16:STROKEAHA121036306. doi: 10.1161/STROKEAHA.121.036306.
    PubMed     Abstract available

    November 2021
  16. GAIST D, Gonzalez-Perez A, Hald SM, Garcia Rodriguez LA, et al
    Higher Risk of Ischemic Stroke After an Intracerebral Hemorrhage Than in General Population: A Cohort Study From the United Kingdom.
    Stroke. 2021 Nov 16:STROKEAHA121037633. doi: 10.1161/STROKEAHA.121.037633.

  17. BLANC C, Blanc G, Boveda S, Calviere L, et al
    Left Atrial Appendage Closure in Patients With Atrial Fibrillation and Coexisting Cerebral Amyloid Angiopathy.
    Stroke. 2021 Nov 9:STROKEAHA121037248. doi: 10.1161/STROKEAHA.121.037248.

  18. SPOSATO LA, Gurol ME
    Advances in Neurocardiology: Focus on Atrial Fibrillation.
    Stroke. 2021;52:3696-3699.

    October 2021
  19. FONTAINE L, Sibon I, Raposo N, Albucher JF, et al
    ASCOD Phenotyping of Stroke With Anterior Large Vessel Occlusion Treated by Mechanical Thrombectomy.
    Stroke. 2021 Oct 27:STROKEAHA121035282. doi: 10.1161/STROKEAHA.121.035282.
    PubMed     Abstract available

  20. FAUCHIER L, Bisson A, Bodin A, Herbert J, et al
    Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation.
    Stroke. 2021 Oct 4:STROKEAHA121034213. doi: 10.1161/STROKEAHA.121.034213.
    PubMed     Abstract available

    September 2021
  21. VYNCKIER J, Kaesmacher J, Wardlaw JM, Roten L, et al
    Phenotypes of Chronic Covert Brain Infarction in Patients With First-Ever Ischemic Stroke: A Cohort Study.
    Stroke. 2021 Sep 16:STROKEAHA121034347. doi: 10.1161/STROKEAHA.121.034347.
    PubMed     Abstract available

  22. LEE SR, Choi EK, Park SH, Jung JH, et al
    Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation.
    Stroke. 2021 Sep 9:STROKEAHA120033338. doi: 10.1161/STROKEAHA.120.033338.
    PubMed     Abstract available

    Direct Oral Anticoagulants and Prevention of Dementia in Nonvalvular Atrial Fibrillation.
    Stroke. 2021 Sep 9:STROKEAHA121035664. doi: 10.1161/STROKEAHA.121.035664.

    August 2021

  24. Correction to: Atherosclerotic Burden and Vascular Risk in Stroke Patients With Atrial Fibrillation.
    Stroke. 2021;52:e523.

    July 2021
  25. MEYA L, Polymeris AA, Schaedelin S, Schaub F, et al
    Oral Anticoagulants in Atrial Fibrillation Patients With Recent Stroke Who Are Dependent on the Daily Help of Others.
    Stroke. 2021 Jul 27:STROKEAHA120033862. doi: 10.1161/STROKEAHA.120.033862.
    PubMed     Abstract available

  26. REDDIN C, Judge C, Loughlin E, Murphy R, et al
    Association of Oral Anticoagulation With Stroke in Atrial Fibrillation or Heart Failure: A Comparative Meta-Analysis.
    Stroke. 2021 Jul 20:STROKEAHA120033910. doi: 10.1161/STROKEAHA.120.033910.
    PubMed     Abstract available

  27. MCCABE JJ, Kelly PJ
    Inflammation, Cholesterol, and Stroke Risk: Building Evidence for a Dual Target Strategy for Secondary Prevention.
    Stroke. 2021 Jul 20:STROKEAHA121035676. doi: 10.1161/STROKEAHA.121.035676.

  28. GRIMALDI-BENSOUDA L, Le Heuzey JY, Ferrieres J, Leys D, et al
    Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors.
    Stroke. 2021 Jul 13:STROKEAHA120032704. doi: 10.1161/STROKEAHA.120.032704.
    PubMed     Abstract available

  29. CHAN YH, Chao TF, Lee HF, Chen SW, et al
    Clinical Outcomes in Atrial Fibrillation Patients With a History of Cancer Treated With Non-Vitamin K Antagonist Oral Anticoagulants: A Nationwide Cohort Study.
    Stroke. 2021 Jul 8:STROKEAHA120033470. doi: 10.1161/STROKEAHA.120.033470.
    PubMed     Abstract available

  30. ALBERS GW, Bernstein R, Brachmann J, Camm AJ, et al
    Reexamination of the Embolic Stroke of Undetermined Source Concept.
    Stroke. 2021 Jul 1:STROKEAHA121035208. doi: 10.1161/STROKEAHA.121.035208.
    PubMed     Abstract available

    June 2021
  31. DING M, Wang R, Kalpouzos G, Laukka EJ, et al
    Cerebral Small Vessel Disease Associated With Atrial Fibrillation Among Older Adults: A Population-Based Study.
    Stroke. 2021 Jun 17:STROKEAHA120031573. doi: 10.1161/STROKEAHA.120.031573.
    PubMed     Abstract available

  32. MAC GRORY B, Landman SR, Ziegler PD, Boisvert CJ, et al
    Detection of Atrial Fibrillation After Central Retinal Artery Occlusion.
    Stroke. 2021 Jun 7:STROKEAHA120033934. doi: 10.1161/STROKEAHA.120.033934.
    PubMed     Abstract available

    May 2021
  33. SUISSA L, Guigonis JM, Graslin F, Robinet-Borgomano E, et al
    Combined Omic Analyzes of Cerebral Thrombi: A New Molecular Approach to Identify Cardioembolic Stroke Origin.
    Stroke. 2021 May 21:STROKEAHA120032129. doi: 10.1161/STROKEAHA.120.032129.
    PubMed     Abstract available

    April 2021
  34. DALMAR A, Singh M, Heis Z, Cumpian TL, et al
    Risk of Atrial Fibrillation and Stroke After Bariatric Surgery in Patients With Morbid Obesity With or Without Obstructive Sleep Apnea.
    Stroke. 2021 Apr 21:STROKEAHA120031920. doi: 10.1161/STROKEAHA.120.031920.
    PubMed     Abstract available

  35. ZHOU Z, Jardine MJ, Li Q, Neuen BL, et al
    Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.
    Stroke. 2021 Apr 20:STROKEAHA120031623. doi: 10.1161/STROKEAHA.120.031623.
    PubMed     Abstract available

  36. GABET A, Guenancia C, Duloquin G, Olie V, et al
    Ischemic Stroke With Atrial Fibrillation: Characteristics and Time Trends 2006 to 2017 in the Dijon Stroke Registry.
    Stroke. 2021 Apr 20:STROKEAHA120030812. doi: 10.1161/STROKEAHA.120.030812.
    PubMed     Abstract available

  37. PARK JH, Chung JW, Bang OY, Kim GM, et al
    Atherosclerotic Burden and Vascular Risk in Stroke Patients With Atrial Fibrillation.
    Stroke. 2021 Apr 2:STROKEAHA120032232. doi: 10.1161/STROKEAHA.120.032232.
    PubMed     Abstract available

    March 2021
  38. STRAMBO D, Sirimarco G, Nannoni S, Perlepe K, et al
    Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Risk of Paradoxical Embolism Score Validation and Atrial Fibrillation Prediction.
    Stroke. 2021 Mar 31:STROKEAHA120032453. doi: 10.1161/STROKEAHA.120.032453.
    PubMed     Abstract available

  39. PACIARONI M, Agnelli G, Giustozzi M, Caso V, et al
    Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention.
    Stroke. 2021 Mar 4:STROKEAHA120031827. doi: 10.1161/STROKEAHA.120.031827.
    PubMed     Abstract available

    February 2021
  40. DE MARCHIS GM, Sposato LA, Kuhne M, Dittrich TD, et al
    New Avenues for Optimal Treatment of Atrial Fibrillation and Stroke Prevention.
    Stroke. 2021 Feb 25:STROKEAHA120032060. doi: 10.1161/STROKEAHA.120.032060.
    PubMed     Abstract available

  41. LABOVITZ AJ, Rose DZ, Fradley MG, Meriwether JN, et al
    Early Apixaban Use Following Stroke in Patients With Atrial Fibrillation: Results of the AREST Trial.
    Stroke. 2021 Feb 25:STROKEAHA120030042. doi: 10.1161/STROKEAHA.120.030042.
    PubMed     Abstract available

  42. CHEN JZ, Thijs VN
    Atrial Fibrillation Following Patent Foramen Ovale Closure: Systematic Review and Meta-Analysis of Observational Studies and Clinical Trials.
    Stroke. 2021 Feb 22:STROKEAHA120030293. doi: 10.1161/STROKEAHA.120.030293.
    PubMed     Abstract available

  43. ZHU W, Ye Z, Chen S, Wu D, et al
    Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients.
    Stroke. 2021 Feb 18:STROKEAHA120031007. doi: 10.1161/STROKEAHA.120.031007.
    PubMed     Abstract available

  44. PARK YJ, Kim JS, Park KM, On YK, et al
    Subclinical Atrial Fibrillation Burden and Adverse Clinical Outcomes in Patients With Permanent Pacemakers.
    Stroke. 2021 Feb 16:STROKEAHA120031822. doi: 10.1161/STROKEAHA.120.031822.
    PubMed     Abstract available

  45. RAMOS-PACHON A, Lopez-Cancio E, Bustamante A, Perez de la Ossa N, et al
    D-Dimer as Predictor of Large Vessel Occlusion in Acute Ischemic Stroke.
    Stroke. 2021 Feb 10:STROKEAHA120031657. doi: 10.1161/STROKEAHA.120.031657.
    PubMed     Abstract available

  46. QURESHI AI, Baskett WI, Huang W, Shyu D, et al
    Acute Ischemic Stroke and COVID-19: An Analysis of 27 676 Patients.
    Stroke. 2021 Feb 4:STROKEAHA120031786. doi: 10.1161/STROKEAHA.120.031786.
    PubMed     Abstract available

    January 2021
  47. LIU H, Li M, Li C, Wang Z, et al
    Nonatrial Fibrillation Patients With Complete P Wave Disappearance: An Overlooked Population With High Stroke Risk.
    Stroke. 2021 Jan 28:STROKEAHA120031666. doi: 10.1161/STROKEAHA.120.031666.
    PubMed     Abstract available

  48. HART RG
    Atrial Fibrillation and Prevention of Embolic Stroke: Personal Reflections.
    Stroke. 2021 Jan 11:STROKEAHA120030420. doi: 10.1161/STROKEAHA.120.030420.

  49. LEE SR, Choi EK, Jung JH, Park SH, et al
    Body Mass Index and Clinical Outcomes in Asian Patients With Atrial Fibrillation Receiving Oral Anticoagulation.
    Stroke. 2021 Jan 11:STROKEAHA120030356. doi: 10.1161/STROKEAHA.120.030356.
    PubMed     Abstract available

  50. KWON S, Lee SR, Choi EK, Lee E, et al
    Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding.
    Stroke. 2021 Jan 8:STROKEAHA120030761. doi: 10.1161/STROKEAHA.120.030761.
    PubMed     Abstract available

    December 2020
  51. KOSHY AN, Enyati A, Weinberg L, Han HC, et al
    Postoperative Atrial Fibrillation and Long-Term Risk of Stroke in Patients Undergoing Liver Transplantation.
    Stroke. 2020 Dec 22:STROKEAHA120031454. doi: 10.1161/STROKEAHA.120.031454.
    PubMed     Abstract available

  52. AGUIAR DE SOUSA D, Katan M
    Promising Use of Automated Electronic Phenotyping: Turning Big Data Into Big Value in Stroke Research.
    Stroke. 2020 Dec 10:STROKEAHA120033061. doi: 10.1161/STROKEAHA.120.033061.

  53. GUAN W, Ko D, Khurshid S, Trisini Lipsanopoulos AT, et al
    Automated Electronic Phenotyping of Cardioembolic Stroke.
    Stroke. 2020 Dec 10:STROKEAHA120030663. doi: 10.1161/STROKEAHA.120.030663.
    PubMed     Abstract available

  54. HUSSEIN HM, Anderson DC
    Small Vessel Disease: Perpetrator or Predictor of Stroke in Patients With Atrial Fibrillation?
    Stroke. 2020 Dec 7:STROKEAHA120032536. doi: 10.1161/STROKEAHA.120.032536.

  55. DU H, Wilson D, Ambler G, Banerjee G, et al
    Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia.
    Stroke. 2020 Dec 7:STROKEAHA120029474. doi: 10.1161/STROKEAHA.120.029474.
    PubMed     Abstract available

  56. PENGO MF, Faini A, Grote L, Ludka O, et al
    Impact of Sleep Apnea on Cardioembolic Risk in Patients With Atrial Fibrillation: Data From the ESADA Cohort.
    Stroke. 2020 Dec 4:STROKEAHA120030285. doi: 10.1161/STROKEAHA.120.030285.
    PubMed     Abstract available

  57. WETMORE JB, Roetker NS, Herzog CA
    Response by Wetmore et al to Letter Regarding Article, "Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation".
    Stroke. 2020;51:e363-e364.

  58. DING WY, Rivera-Caravaca JM, Lip GYH
    Letter by Ding et al Regarding Article, "Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation".
    Stroke. 2020;51:e361-e362.

    November 2020
  59. SENADEERA SC, Palmer DG, Keenan R, Beharry J, et al
    Left Atrial Appendage Thrombus Detected During Hyperacute Stroke Imaging Is Associated With Atrial Fibrillation.
    Stroke. 2020 Nov 9:STROKEAHA120030258. doi: 10.1161/STROKEAHA.120.030258.
    PubMed     Abstract available

    October 2020
  60. SPENCE JD, Azarpazhooh MR, Larsson SC, Bogiatzi C, et al
    Stroke Prevention in Older Adults: Recent Advances.
    Stroke. 2020 Oct 30:STROKEAHA120031707. doi: 10.1161/STROKEAHA.120.031707.
    PubMed     Abstract available

  61. GROSSE GM, Sieweke JT, Biber S, Ziegler NL, et al
    Nonstenotic Carotid Plaque in Embolic Stroke of Undetermined Source: Interplay of Arterial and Atrial Disease.
    Stroke. 2020 Oct 12:STROKEAHA120030537. doi: 10.1161/STROKEAHA.120.030537.
    PubMed     Abstract available

  62. HAAS K, Rucker V, Hermanek P, Misselwitz B, et al
    Association Between Adherence to Quality Indicators and 7-Day In-Hospital Mortality After Acute Ischemic Stroke.
    Stroke. 2020 Oct 12:STROKEAHA120029968. doi: 10.1161/STROKEAHA.120.029968.
    PubMed     Abstract available

  63. ZHOU E, Lord A, Boehme A, Henninger N, et al
    Risk of Ischemic Stroke in Patients With Atrial Fibrillation After Extracranial Hemorrhage.
    Stroke. 2020 Oct 8:STROKEAHA120029959. doi: 10.1161/STROKEAHA.120.029959.
    PubMed     Abstract available

  64. CHOI KH, Kim JH, Lee C, Kim JM, et al
    Microbleeds and Outcome in Patients With Acute Ischemic Stroke and Atrial Fibrillation Taking Anticoagulants.
    Stroke. 2020 Oct 8:STROKEAHA120030300. doi: 10.1161/STROKEAHA.120.030300.
    PubMed     Abstract available

    September 2020
  65. ELKIND MSV, Boehme AK, Smith CJ, Meisel A, et al
    Infection as a Stroke Risk Factor and Determinant of Outcome After Stroke.
    Stroke. 2020 Sep 8:STROKEAHA120030429. doi: 10.1161/STROKEAHA.120.030429.
    PubMed     Abstract available

  66. Correction to: Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study.
    Stroke. 2020;51:e271.

    August 2020
  67. JUNG YH, Kim YD, Kim J, Han SW, et al
    Initial Stroke Severity in Patients With Atrial Fibrillation According to Antithrombotic Therapy Before Ischemic Stroke.
    Stroke. 2020 Aug 19:STROKEAHA120030138. doi: 10.1161/STROKEAHA.120.030138.
    PubMed     Abstract available

  68. KAMEL H, Navi BB, Parikh NS, Merkler AE, et al
    Machine Learning Prediction of Stroke Mechanism in Embolic Strokes of Undetermined Source.
    Stroke. 2020 Aug 12:STROKEAHA120029305. doi: 10.1161/STROKEAHA.120.029305.
    PubMed     Abstract available

  69. NGUYEN-HUYNH MN, Tang XN, Vinson DR, Flint AC, et al
    Acute Stroke Presentation, Care, and Outcomes in Community Hospitals in Northern California During the COVID-19 Pandemic.
    Stroke. 2020 Aug 7:STROKEAHA120031099. doi: 10.1161/STROKEAHA.120.031099.
    PubMed     Abstract available

  70. SEIFFGE DJ, Goeldlin M
    Art of Anticoagulation After Recent Ischemic Stroke.
    Stroke. 2020 Aug 6:STROKEAHA120030997. doi: 10.1161/STROKEAHA.120.030997.

  71. YAGHI S, Mistry E, Liberman AL, Giles J, et al
    Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study.
    Stroke. 2020 Aug 6:STROKEAHA120028867. doi: 10.1161/STROKEAHA.120.028867.
    PubMed     Abstract available

    July 2020
  72. GIUSTOZZI M, Acciarresi M, Agnelli G, Caso V, et al
    Safety of Anticoagulation in Patients Treated With Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation.
    Stroke. 2020 Jul 10:STROKEAHA120030143. doi: 10.1161/STROKEAHA.120.030143.
    PubMed     Abstract available

  73. WETMORE JB, Roetker NS, Yan H, Reyes JL, et al
    Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation.
    Stroke. 2020 Jul 9:STROKEAHA120028934. doi: 10.1161/STROKEAHA.120.028934.
    PubMed     Abstract available

  74. ONG E, Meseguer E, Guidoux C, Lavallee PC, et al
    Prevalence and Outcome of Potential Candidates for Left Atrial Appendage Closure After Stroke With Atrial Fibrillation: WATCH-AF Registry.
    Stroke. 2020 Jul 9:STROKEAHA120029267. doi: 10.1161/STROKEAHA.120.029267.
    PubMed     Abstract available

    June 2020
  75. TANAKA K, Koga M, Bae HJ
    Response by Tanaka et al to Letter Regarding Article, "Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke".
    Stroke. 2020 Jun 26:STROKEAHA120030414. doi: 10.1161/STROKEAHA.120.030414.

  76. HSIEH CY, Sung SF
    Letter by Hsieh and Sung Regarding Article, "Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke".
    Stroke. 2020 Jun 26:STROKEAHA120030101. doi: 10.1161/STROKEAHA.120.030101.

  77. VAN GANSE E, Danchin N, Mahe I, Hanon O, et al
    Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study.
    Stroke. 2020 Jun 16:STROKEAHA120028825. doi: 10.1161/STROKEAHA.120.028825.
    PubMed     Abstract available

  78. MENTIAS A, Heller E, Vaughan Sarrazin M
    Comparative Effectiveness of Rivaroxaban, Apixaban, and Warfarin in Atrial Fibrillation Patients With Polypharmacy.
    Stroke. 2020 Jun 10:STROKEAHA120029541. doi: 10.1161/STROKEAHA.120.029541.
    PubMed     Abstract available

  79. CHEW DS, Rennert-May E, Spackman E, Mark DB, et al
    Cost-Effectiveness of Extended Electrocardiogram Monitoring for Atrial Fibrillation After Stroke: A Systematic Review.
    Stroke. 2020 Jun 5:STROKEAHA120029340. doi: 10.1161/STROKEAHA.120.029340.
    PubMed     Abstract available

    May 2020
  80. KRITTAYAPHONG R, Winijkul A, Kunjara-Na-Ayudhya R, Apiyasawat S, et al
    Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population: The COOL-AF Registry.
    Stroke. 2020 May 11:STROKEAHA120029295. doi: 10.1161/STROKEAHA.120.029295.
    PubMed     Abstract available

  81. BODIN A, Bisson A, Gaborit C, Herbert J, et al
    Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions.
    Stroke. 2020 May 11:STROKEAHA120029048. doi: 10.1161/STROKEAHA.120.029048.
    PubMed     Abstract available

  82. Correction to: Ischemic Stroke and Bleeding: Clinical Benefit of Anticoagulation in Atrial Fibrillation After Intracerebral Hemorrhage.
    Stroke. 2020;51:e100.

  83. Correction to: Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke.
    Stroke. 2020;51:e99.

  84. MURTHY SB, Wu X, Diaz I, Parasram M, et al
    Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events.
    Stroke. 2020;51:1464-1469.
    PubMed     Abstract available

    April 2020
  85. LEE SR, Choi EK, Lip GYH
    Response by Lee et al to Letter Regarding Article, "Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage".
    Stroke. 2020 Apr 27:STROKEAHA120029551. doi: 10.1161/STROKEAHA.120.029551.

  86. LIANG B, Zhao YX, Gu N
    Letter by Liang et al Regarding Article, "Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage".
    Stroke. 2020 Apr 27:STROKEAHA120029434. doi: 10.1161/STROKEAHA.120.029434.

  87. KOKKINIDIS DG, Zareifopoulos N, Theochari CA, Arfaras-Melainis A, et al
    Association Between Atrial Fibrillation and Cognitive Impairment in Individuals With Prior Stroke: A Meta-Analysis and Meta-Regression Analysis.
    Stroke. 2020 Apr 21:STROKEAHA119027815. doi: 10.1161/STROKEAHA.119.027815.
    PubMed     Abstract available

  88. MCMAHON NE, Bangee M, Benedetto V, Bray EP, et al
    Etiologic Workup in Cases of Cryptogenic Stroke: A Systematic Review of International Clinical Practice Guidelines.
    Stroke. 2020 Apr 13:STROKEAHA119027123. doi: 10.1161/STROKEAHA.119.027123.
    PubMed     Abstract available

  89. KHURSHID S, Trinquart L, Weng LC, Hulme OL, et al
    Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke.
    Stroke. 2020 Apr 7:STROKEAHA120028837. doi: 10.1161/STROKEAHA.120.028837.
    PubMed     Abstract available

    March 2020
  90. ANDREASEN C, Gislason GH, Kober L, Abdulla J, et al
    Incidence of Ischemic Stroke in Individuals With and Without Aortic Valve Stenosis: A Danish Retrospective Cohort Study.
    Stroke. 2020 Mar 27:STROKEAHA119028389. doi: 10.1161/STROKEAHA.119.028389.
    PubMed     Abstract available

  91. BEHARRY J, Waters MJ, Drew R, Fink JN, et al
    Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke.
    Stroke. 2020 Mar 25:STROKEAHA119028327. doi: 10.1161/STROKEAHA.119.028327.
    PubMed     Abstract available

    February 2020
  92. CAO S, Wang J, Xia M
    Letter by Cao et al Regarding Article, "Prevalence of Microembolic Signals in Embolic Stroke of Undetermined Source and Other Subtypes of Ischemic Stroke".
    Stroke. 2020 Feb 26:STROKEAHA119028801. doi: 10.1161/STROKEAHA.119.028801.

    January 2020
  93. OLIVIERI O, Cappellari M, Turcato G, Bonetti B, et al
    Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII.
    Stroke. 2020;51:61-68.
    PubMed     Abstract available

  94. MURTHY SB, Diaz I, Wu X, Merkler AE, et al
    Risk of Arterial Ischemic Events After Intracerebral Hemorrhage.
    Stroke. 2020;51:137-142.
    PubMed     Abstract available

  95. GUTIERREZ J, Gil-Guevara A, Ramaswamy S, DeRosa J, et al
    Classification of Covert Brain Infarct Subtype and Risk of Death and Vascular Events.
    Stroke. 2020;51:90-98.
    PubMed     Abstract available

    December 2019
  96. SHAHJOUEI S, Tsivgoulis G, Goyal N, Sadighi A, et al
    Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis.
    Stroke. 2019 Dec 30:STROKEAHA119026426. doi: 10.1161/STROKEAHA.119.026426.
    PubMed     Abstract available

    September 2019
  97. LERARIO MP, Grotta JC, Merkler AE, Omran SS, et al
    Association Between Intravenous Thrombolysis and Anaphylaxis Among Medicare Beneficiaries With Acute Ischemic Stroke.
    Stroke. 2019 Sep 13:STROKEAHA119026861. doi: 10.1161/STROKEAHA.119.026861.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.